Table 5 Association between size of the CD4+ CD25high population and use of corticosteroids.
CD4+ CD25high (%) | Corticosteroids | Univariate analysis, OR (95% CI), p value* | Multivariate analysis†, OR (95% CI), p value* | |
---|---|---|---|---|
Non–users, n (%) | Users, n (%) | |||
Low (<8.4) | 43 (58.9) | 30 (41.1) | ||
High (⩾8.4) | 11 (29.7) | 26 (70.3) | 3.39 (1.45 to 7.88) 0.005 | 3.59 (1.35 to 9.51) 0.010 |
*Calculated by unconditional binary logistic regression modelling, using the percentage of CD4+ CD25high T cells as the dependent variable and patients without glucocorticoid treatment as reference.
†Adjusted for clinical parameters: malar rash, discoid lesions, photosensitivity, oral ulcers, arthritis, serositis, renal, neurological or haematological disorder, and level of anti‐double‐stranded DNA antibodies at the time of sampling.